Worldwide Patient Blood Management Industry to 2025 - Growing Awareness Regarding the Safety of Donated Blood Presents Opportunities - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Global Patient Blood Management Market (2020-2025) by Product, Component, End User, Geography and the Impact of Covid-19 with Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering.

The Global Patient Blood Management Market is estimated to be USD 9.9 Bn in 2020 and is expected to reach USD 13.9 Bn by 2025 growing at a CAGR of 7%.

Patient blood management (PBM) is an evidence-based, integrative, multi-disciplinary approach to optimize the care of patients in critical situations and who might need a transfusion. Also, it is used for minimizing blood loss at the time of surgical procedures and maintain the blood level in the body of the patient. It saves and improves the lives of patients by providing a safe and reliable supply of blood components, organs, stem cells, tissues, and related services. Blood Management is carried out by doctors for patients that possess the risk of blood loss at the time of surgical intervention. It has major applications in pathology labs, diagnostic clinics and centers, hospitals, and blood banks. Some of its types include instruments, accessories, software, and reagents and kits.

This technique is designed to ensure optimal patient outcomes while maintaining the blood supply to guarantee that blood components are available for patients when they are needed. The accelerating demand for blood banks across the globe and the prevailing ratio of blood diseases such as anemia, leukemia has catered the patient blood management. Patient blood management is an international initiative for transfusion medicine that is supported by the World Health Organization (WHO).

The rising number of accidental incidences, trauma cases, and surgical procedures fuels the growth of the global patient blood management market. The increased awareness for the value of donated blood through the various verticals of healthcare infrastructure has boosted the dimensional growth of the Patient Blood Management Market during the forecast period. Increment in the growth of blood donors and rewarding assistance offered in exchange for blood donation is growing at a strong pace.

The high cost associated with the automated systems is expected to hinder the growth of the Global Patient Blood Management Market. High costs associated with the regulatory requirements, infection testing, and hospital administration costs such as initial project costs, personnel salaries, equipment costs, outside resources, and ongoing project costs make automation more expensive. The Global Patient Blood Management Market is facing challenges from the high costs of automated systems, limiting the market growth in developing regions.

Market Dynamics

Drivers

• Increasing Demand for Donated Blood
• Increasing Number of Blood Donations and Blood Donors
• Rising Prevalence of Target Diseases
• Technological Advancements in the Patient Blood Management Industry

Restraints

• High Cost Associated With Automated Systems

Opportunities

• Market Penetration Opportunities in Developing Countries
• Growing Awareness Regarding the Safety of Donated Blood

Challenges

• The risk associated with the Transfusion procedures

Why buy this report?

• The report offers a comprehensive evaluation of the Global Patient Blood Management Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
• The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
• The report includes an in-depth market analysis using Porter's 5 force model and the Ansoff Matrix. The impact of COVID-19 on the market is also featured in the report.
• The report also contains the competitive analysis using the Competitive Quadrant, the analyst's proprietary competitive positioning tool.

Report Highlights:

• A complete analysis of the market including parent industry
• Important market dynamics and trends
• Market segmentation
• Historical, current, and projected size of the market based on value and volume
• Market shares and strategies of key players
• Recommendations to companies for strengthening their foothold in the market

Companies Mentioned

• Haemonetics Corporation
• Fresenius Se & Co. KGaA
• Terumo Corporation
• Immucor, Inc.
• B. Braun Melsungen AG
• Macopharma
• Biomerieux SA
• Asahi Kasei Medical Co. Ltd. (A Subsidiary of Asahi Kasei Corporation)
• Kaneka Corporation
• Bio-Rad Laboratories, Inc.
• Abbott Laboratories
• Grifols, S.A.
• F. Hoffmann-La Roche LTD.
• Livanova PLC
• Danaher Corporation
• Mediware Information Systems
• Kawasumi Laboratories, Inc.
• Haier Biomedical
• Diatron
• Bag Diagnostics GmbH

For more information about this report visit https://www.researchandmarkets.com/r/euozar